Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Real-World Case Study: 220 lb Athlete on Retatrutide Baseline : 220 lbs, ~25% body fat (55 lbs fat, 165 lbs muscle) Protocol : Retatrutide 2.4 mg weekly 2,300 kcal daily, 180g protein 5x/week lifting (push-pull split) MOTS-C 5 mg daily, GHK-Cu 0.5 mg daily Duration: 16 weeks Expected results: Total weight loss: 20-22 lbs (in line with Phase 3) Fat loss: ~17-18 lbs (83% of total) Muscle loss: 2-3 lbs (17% of total) Final body composition: 203-205 lbs, 17-18% body fat, 165-167 lbs muscle Outcome : 17 lbs of pure fat loss with minimal muscle damagea physique transformation that would take 6 months of traditional dieting and produce more muscle loss
(France) "FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications"
Both medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Gorgojo-Martinez JJ, Mezquita-Raya P, Carretero-Gomez J, Castro A, Cebrian-Cuenca A, de Torres-Sanchez A, et al
